Technological advancements, new product approvals, and advantages such as compact design and mobility are some other factors driving the market. For instance, in 2016, the U.S. FDA approved Dexcom G5 mobile continuous glucose monitoring system for patients with type 1 and type 2 diabetes for real-time glucose monitoring every five minutes. In 2017, monitoring devices held the largest market share in terms of revenue owing to increasing adoption of monitoring systems by hospitals, clinics, and other healthcare facilities for better disease management
Typed of Monitoring Devices
- Cardiac Monitoring
- - - - Resting ECG System